Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096802804> ?p ?o ?g. }
- W3096802804 endingPage "3297" @default.
- W3096802804 startingPage "3297" @default.
- W3096802804 abstract "Background: In glioblastoma (GB), tissue is required for accurate diagnosis and subtyping. Tissue can be obtained through resection or (stereotactic) biopsy, but these invasive procedures provide risks for patients. Extracellular vesicles (EVs) are small, cell-derived vesicles that contain miRNAs, proteins, and lipids, and possible candidates for liquid biopsies. GB-derived EVs can be found in the blood of patients, but it is difficult to distinguish them from circulating non-tumor EVs. 5-aminolevulinic acid (5-ALA) is orally administered to GB patients to facilitate tumor visualization and maximal resection, as it is metabolized to fluorescent protoporphyrin IX (PpIX) that accumulates in glioma cells. In this study, we assessed whether PpIX accumulates in GB-derived EVs and whether these EVs could be isolated and characterized to enable a liquid biopsy in GB. Methods: EVs were isolated from the conditioned media of U87 cells treated with 5-ALA by differential ultracentrifugation. Blood samples were collected and processed from healthy controls and patients undergoing 5-ALA guided surgery for GB. High-resolution flow cytometry (hFC) enabled detection and sorting of PpIX-positive EVs, which were subsequently analyzed by digital droplet PCR (ddPCR). Results: PpIX-positive EVs could be detected in conditioned cell culture media as well as in patient samples after administration of 5-ALA. By using hFC, we could sort the PpIX-positive EVs for further analysis with ddPCR, which indicated the presence of EVs and GB-associated miRNAs. Conclusion: GB-derived EVs can be isolated from the plasma of GB patients by using 5-ALA induced fluorescence. Although many challenges remain, our findings show new possibilities for the development of blood-based liquid biopsies in GB patients." @default.
- W3096802804 created "2020-11-09" @default.
- W3096802804 creator A5001441278 @default.
- W3096802804 creator A5005526815 @default.
- W3096802804 creator A5013779863 @default.
- W3096802804 creator A5014780359 @default.
- W3096802804 creator A5014953188 @default.
- W3096802804 creator A5016867577 @default.
- W3096802804 creator A5035909058 @default.
- W3096802804 creator A5051288617 @default.
- W3096802804 creator A5063693691 @default.
- W3096802804 creator A5078404048 @default.
- W3096802804 creator A5080375817 @default.
- W3096802804 creator A5083432070 @default.
- W3096802804 date "2020-11-07" @default.
- W3096802804 modified "2023-10-17" @default.
- W3096802804 title "Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients" @default.
- W3096802804 cites W1144614754 @default.
- W3096802804 cites W1448866238 @default.
- W3096802804 cites W1587922612 @default.
- W3096802804 cites W1793480972 @default.
- W3096802804 cites W1959468401 @default.
- W3096802804 cites W1967224311 @default.
- W3096802804 cites W1972380031 @default.
- W3096802804 cites W1975320047 @default.
- W3096802804 cites W1985805774 @default.
- W3096802804 cites W1987604193 @default.
- W3096802804 cites W2013672443 @default.
- W3096802804 cites W2016183080 @default.
- W3096802804 cites W2019357090 @default.
- W3096802804 cites W2019917125 @default.
- W3096802804 cites W2024206172 @default.
- W3096802804 cites W2028164547 @default.
- W3096802804 cites W2030017878 @default.
- W3096802804 cites W2030701238 @default.
- W3096802804 cites W2036044314 @default.
- W3096802804 cites W2038744035 @default.
- W3096802804 cites W2051355816 @default.
- W3096802804 cites W2059459219 @default.
- W3096802804 cites W2084349069 @default.
- W3096802804 cites W2084666131 @default.
- W3096802804 cites W2093013992 @default.
- W3096802804 cites W2096287682 @default.
- W3096802804 cites W2104184378 @default.
- W3096802804 cites W2104610341 @default.
- W3096802804 cites W2113671336 @default.
- W3096802804 cites W2113942802 @default.
- W3096802804 cites W2115713194 @default.
- W3096802804 cites W2118311655 @default.
- W3096802804 cites W2125372543 @default.
- W3096802804 cites W2128111546 @default.
- W3096802804 cites W2150309717 @default.
- W3096802804 cites W2158681922 @default.
- W3096802804 cites W2160033023 @default.
- W3096802804 cites W2167560492 @default.
- W3096802804 cites W2212349068 @default.
- W3096802804 cites W2225938139 @default.
- W3096802804 cites W2294312700 @default.
- W3096802804 cites W2297337761 @default.
- W3096802804 cites W2330004628 @default.
- W3096802804 cites W2484888335 @default.
- W3096802804 cites W2565271826 @default.
- W3096802804 cites W2738946651 @default.
- W3096802804 cites W2751366772 @default.
- W3096802804 cites W2766975063 @default.
- W3096802804 cites W2768340401 @default.
- W3096802804 cites W2801065422 @default.
- W3096802804 cites W2807926135 @default.
- W3096802804 cites W2894662202 @default.
- W3096802804 cites W2904802348 @default.
- W3096802804 cites W2905270996 @default.
- W3096802804 cites W2911769095 @default.
- W3096802804 cites W2915138723 @default.
- W3096802804 cites W2946769188 @default.
- W3096802804 cites W2969040340 @default.
- W3096802804 cites W2980742761 @default.
- W3096802804 cites W2990393207 @default.
- W3096802804 cites W4245392732 @default.
- W3096802804 cites W755213597 @default.
- W3096802804 doi "https://doi.org/10.3390/cancers12113297" @default.
- W3096802804 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7695169" @default.
- W3096802804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33171819" @default.
- W3096802804 hasPublicationYear "2020" @default.
- W3096802804 type Work @default.
- W3096802804 sameAs 3096802804 @default.
- W3096802804 citedByCount "9" @default.
- W3096802804 countsByYear W30968028042021 @default.
- W3096802804 countsByYear W30968028042022 @default.
- W3096802804 countsByYear W30968028042023 @default.
- W3096802804 crossrefType "journal-article" @default.
- W3096802804 hasAuthorship W3096802804A5001441278 @default.
- W3096802804 hasAuthorship W3096802804A5005526815 @default.
- W3096802804 hasAuthorship W3096802804A5013779863 @default.
- W3096802804 hasAuthorship W3096802804A5014780359 @default.
- W3096802804 hasAuthorship W3096802804A5014953188 @default.
- W3096802804 hasAuthorship W3096802804A5016867577 @default.
- W3096802804 hasAuthorship W3096802804A5035909058 @default.
- W3096802804 hasAuthorship W3096802804A5051288617 @default.